Skip to search formSkip to main contentSkip to account menu

Decarboxylase inhibitor

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryClinical trials on the effect of l-DOPA and decarboxylase inhibitor, Ro 4-4602, in the long-term treatment of Parkinson's… 
1993
1993
1. Stride length is highly relevant to mobility and is sensitive to the effects of levodopa in Parkinsonism. Its selection as the… 
1992
1992
The effects of combined administration of bombesin and the ornithine decarboxylase (ODC) inhibitor 1,3‐diaminopropane (DAP) on… 
1989
1989
We evaluated the effect of administration of L‐dopa, alone or in combination with a peripheral decarboxylase inhibitor, on plasma… 
1988
1988
In an open study 25 depressed patients were treated with L-5-hydroxytryptophan (L-5-HTP) either alone or in combination with a… 
1983
1983
  • N. Parmar
  • International journal of tissue reactions
  • 1983
  • Corpus ID: 39009439
The gastric anti-ulcer activity of a specific histidine decarboxylase inhibitor naringenin, the aglycone of naringin, a naturally… 
Highly Cited
1977
Highly Cited
1977
Three parkinsonian patients who were nonresponders to levodopa treatment did not improve when shifted to levodopa-decarboxylase… 
1977
1977
Carbidopa, a selective extracerebral decarboxylase inhibitor, was given to 10 normal volunteers to determine its effects on… 
1973
1973
Concentrations of homovanijlic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF) were studied…